- Fertility drugs may pose some uterine cancer risk (Nov 24)
 - UPDATE 1-Norway's Clavis signs $380 mln cancer drug deal (Nov 24)
 - UPDATE 2-Aeterna stock jumps, ebbs after cancer trial data (Nov 24)
 - FEATURE-"Cancer of fraud" permeates US healthcare system (08:04 AM EST)
 - Selenium supplementation may boost cholesterol (Nov 24)